Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Genome Designs Partners with SciDM Group

Published: Thursday, April 26, 2012
Last Updated: Thursday, April 26, 2012
Bookmark and Share
Securing high performance bioinformatics tools for internal pipelines and custom projects.

Genome Designs, Inc. has announced a partnership with SciDM Group, a bioinformatics tools developer.

Genome Designs will be using SciDM Group’s high performance database engine, transcriptomics data processing pipeline, and high throughput sequence comparison technology.

The tools will be used to augment Genome Designs’ existing genome annotation pipelines and to boost custom software development projects for clients.

“SciDM Group strives to provide computational biologists with fast and flexible data management and bioinformatics tools, capable of keeping the pace with the progress of high-throughput data acquisition technologies, for example, with the recent avalanche of sequencing data,” said Denis Kaznadzey, the leader of SciDM Group.

Kaznadzey continued, “Our tools are free, most are open source and available for download from public repositories. However, they require integration with the client’s system. Our partnership with Genome Designs goes beyond just another vendor-client relationship: they are planning to provide installation and integration services for our products”.

SciDM Group’s flagship product, a database management system, is a zero-maintenance object-relational database engine optimized for dealing with extremely large volumes of data.

On typical bioinformatics tasks like sequence assembly and clustering, SciDM Data Manager operates thousands of times faster than conventional database engines, including popular commercial brands.

Other tools by SciDM Group similarly allow considerable performance optimization and subsequent gain in speed: QSimScan (Quick SIMilarity SCANner) performs 5 to 100 times faster than standard NCBI BLAST depending on search parameters, and EST pipeline efficiently converts raw transcriptomics data into normalized gene expression profiles.

“Since our beginning of operation, we have seen a considerable interest in our custom genome annotation and metabolic engineering services. However, our potential clients often needed more than that: we experienced a strong demand for custom software tools,” commented Natalia Alexandrova, CEO of Genome Designs.

Alexandrova continued, “Originally, such projects have been beyond our scope, but our partnership with SciDM Group will allow us to shorten development cycles and deliver robust systems without changing the focus of the company, and to higher customer’s satisfaction”.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Genome Designs Receives Seed Financing and Starts Operation
Company has received seed financing from undisclosed private investors.
Wednesday, February 08, 2012
Scientific News
Gene Therapy for Metabolic Liver Diseases
Researchers have tested gene therapy in pigs from hereditary tyrosinemia type 1, with corrected liver cells being transplanted into the diseased liver.
Gene Terapy for Muscle Wasting Developed
New gene therapy could save millions of people suffering from muscle wasting disease.
Gene-Editing 'Toolbox' Targets Multiple Genes Simultaneously
Researchers have designed a system that modifies, or edits, multiple genes in a genome at once while minimising unintentional effects.
Discovering the First Farmers
Genetic analyses reveal a collection of highly distinct groups in the Near East and Europe at the dawn of agriculture.
Fighting Cancer Through Protein Pathways
Researchers have found a new drug target within a protein production pathway critical to regulating growth and proliferation of cells.
Mutations in DNA-Repair Genes Found in Advanced Prostate Cancers
New findings indicate that nearly 12% of male advanced prostate cancer sufferers have inherited mutation in DNA-repair genes.
Ice Bucket Challenge Instrumental in Gene Discovery
Donations from the ALS Ice Bucket Chellenge allowed for the largest-ever study of inherited ALS, which identified a new ALS gene.
Triple-Action Therapy Patch Shows Promise
Patch that delivers drug, gene, and light-based therapy to tumor sites shows promising results in mice.
Cancer Gene-Drug Combinations Ripe for Precision Medicine
The study aims to expand the number of cancer gene mutations that can be paired with a precision therapy.
Targeting BRAF Mutations in Thyroid Cancer
Treating metastatic thyroid cancer patients harboring a BRAF mutation with vemurafenib showed anti-tumor activity in a third of patients.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!